Literature DB >> 324008

Physiological considerations important for the management of vasospasm.

T M Sundt, J Szurszewski, F W Sharbrough.   

Abstract

The physiological mechanisms of known importance in the control of cerebral blood flow (CBF) and smooth muscle contraction and relaxation are reviewed. The pathophysiology of vasospasm following subarachnoid hemorrhage (SAH) is correlated with an alteration of these mechanisms. It is emphasized that smooth muscle relaxation is an energy-dependent process and that vasodilators require a functional smooth muscle membrane that may be severely impaired in ischemia or subarachnoid hemorrhage. The temporal profile of ischemia from spasm is correlated with the pathophysiology of altered metabolism of smooth muscle. The relevance of this complication to the timing of aneurysm surgery in 337 cases operated by one surgeon is considered along with various drug regimens suggested for its management.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324008

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Evaluation of the prognostic indicators of giant intracranial aneurysms.

Authors:  Prasad S S V Vannemreddy; Ali Nourbakhsh; Anil Nanda
Journal:  Skull Base       Date:  2011-01

2.  Subarachnoid haemorrhage: older patients have low cerebral blood flow.

Authors:  C H Meyer; D Lowe; M Meyer; P L Richardson; G Neil-Dwyer
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

Review 3.  Cerebral vasospasm as a complication of aneurysmal subarachnoid hemorrhage: a brief review.

Authors:  A Spallone
Journal:  Ital J Neurol Sci       Date:  1985-03

4.  Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.

Authors:  M Guggiari; F Dagreou; M Rivierez; P Mottet; S Gallais; J Philippon; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.